Lene Juel Rasmussen

Late-life semaglutide treatment slows ageing and extends lifespan in female mice

Abstract Pharmacological glucagon-like peptide-1 receptor (GLP-1R) activation reduces food intake and is an effective therapy for type 2 diabetes and obesity 1 . The use of GLP-1 medicines has revealed pleiotropic beneficial effects beyond glucose and weight control 2–5 , but lit...